Kukhudzidwa Kwachibale: 96.97% (95% CI: 83.35% ~ 99.99%)
Zachibale: 100.00% (95% CI: 97.29% ~100.00%)
Kulondola: 99.50% (95%CI:96.94% ~99.99%)
Zotsatira zofulumira mu mphindi 15-30 Rapid antigen kit AMRDT120
Kuyesa kofulumira kwa kuzindikira kwamtundu wa neutralizing
ma antibodies ku SARS-CoV-2 kapena katemera wake m'magazi athunthu, seramu, kapena plasma.
Tsatanetsatane wa Phukusi: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.
Kukhudzidwa Kwachibale: 96.97% (95% CI: 83.35% ~ 99.99%)
Zachibale: 100.00% (95% CI: 97.29% ~100.00%)
Kulondola: 99.50% (95%CI:96.94% ~99.99%)
Tchikwama zojambulidwa, zokhala ndi makaseti oyesera ndi ma desiccants *20
Zoyeserera zoyeserera * Mbale 20;
Zotsitsa zotayidwa * 20;
Lancet *20
Lodine swab * 20
Malangizo ogwiritsira ntchito*1
Zotsatira zofulumira mu mphindi 15-30 Rapid antigen kit AMRDT120 CHOKOLERA KUGWIRITSA NTCHITO
Mayeso a SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) ndi kuyesa kwachangu kwa chromatographic immunoassay kuti muzindikire mwatsatanetsatane ma antibodies ku SARS-CoV-2 m'magazi athunthu, seramu, kapena plasma.
Zotsatira zofulumira pakadutsa mphindi 15-30 zida za antigen zofulumira AMRDT120 PRINCIPLE
Mayeso a SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) ndi ozindikira ma antibodies ku SARS-CoV-2 kapena katemera wake.Ma cell surface receptor angiotensin converting enzyme-2 (ACE2) amakutidwa m'chigawo choyeserera komanso recombinant receptor-binding domain (RBD) yolumikizidwa ndi tinthu tating'onoting'ono.
Pakuyesa, ngati pali ma antibodies a SARS-CoV-2 osalowererapo, amatha kuchitapo kanthu ndi protein ya RBD-particle conjugate ndipo osachita ndi mapuloteni ophimbidwa kale a ACE2.Kusakanizako kumasunthira mmwamba pa nembanembayo motengera chromatographically ndi capillary action ndipo sakanagwidwa ndi antigen yomwe idakutidwa kale.Mayeso a SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) ali ndi tinthu tating'ono ta mapuloteni a RBD.Mapuloteni a ACE2 amakutidwa m'chigawo choyesera.